Switching from phenobarbital to levetiracetam is not the standard approach for poorly controlled canine epilepsy — the evidence supports adding levetiracetam as adjunctive therapy rather than replacing phenobarbital, and doing so requires a substantially higher levetiracetam dose than used in monotherapy.
Phenobarbital induces levetiracetam clearance in a dose-dependent manner, making concurrent dosing pharmacokinetically complex. Phenobarbital co-administration increases levetiracetam clearance to 187 mL/h/kg compared to 71.8 mL/h/kg with bromide alone, resulting in significantly lower peak concentrations (37.5 μg/mL vs. 73.4 μg/mL at a normalized dose of 26.4 mg/kg) Journal of Vete…. This interaction occurs predictably in the majority of dogs comedicated with both drugs Journal of Vete….
When levetiracetam is added to phenobarbital, the starting dose must be substantially higher than monotherapy dosing. At a mean phenobarbital dose of 7 mg/kg/day, a levetiracetam dose of 216 mg/kg/day (72 mg/kg PO q8h) is estimated to be necessary to achieve serum concentrations of at least 20 μg/mL Journal of Vete…. By comparison, the recommended monotherapy starting dose is 33 mg/kg PO q8h Journal of Vete…. The immediate-release formulation is dosed at 20–60 mg/kg PO q8h; the extended-release formulation at 30 mg/kg PO q12h MSD Vet Manuals.
Levetiracetam monotherapy has not demonstrated efficacy equivalent to phenobarbital in dogs. Five of six levetiracetam-treated dogs withdrew from a monotherapy trial within 2–5 months due to insufficient seizure control, while five of six phenobarbital-treated dogs were classified as responders (≥50% reduction in seizures per month) The Veterinary…. Levetiracetam-treated dogs showed no significant reduction in monthly seizure frequency, whereas phenobarbital-treated dogs did The Veterinary…. This makes an outright switch — discontinuing phenobarbital in favor of levetiracetam alone — unsupported by current evidence.
If the goal is to reduce phenobarbital exposure due to adverse effects (e.g., hepatopathy), the target trough phenobarbital concentration is 15–35 μg/mL in dogs, and dose reduction toward the lower end of this range, combined with levetiracetam add-on, is the more evidence-based strategy than complete substitution MSD Vet Manuals. Aiming for the upper end of the phenobarbital therapeutic range (30–35 μg/mL) with adjunctive levetiracetam is specifically recommended for dogs with epileptogenic intracranial disease and uncontrolled seizures Journal of Vete….
Therapeutic drug monitoring is essential when levetiracetam is used alongside phenobarbital. The human reference range of 5–45 μg/mL is commonly cited in veterinary medicine, but a minimum therapeutic concentration has not been established in dogs Journal of Vete…+1. When targeting a minimum of 10 μg/mL, 100% of dogs receiving levetiracetam extended-release concurrently with phenobarbital fell below this threshold at one or more time points Journal of Vete…. Individual serum concentration measurement and dose titration based on clinical response are required Journal of Vete…+1.
Adverse effects of levetiracetam are uncommon and include vomiting, ataxia, sedation, hyperexcitability, anorexia, and polyuria/polydipsia at routine doses in dogs MSD Vet Manuals. No hepatotoxicity is associated with levetiracetam, which is relevant when phenobarbital-induced hepatopathy is the reason for considering a change MSD Vet Manuals.
| Drug/Protocol | Dose | Efficacy | Key Caveat |
|---|---|---|---|
| Levetiracetam monotherapy (IR) | 20–60 mg/kg PO q8h | 0/6 dogs met ≥50% seizure reduction The Veterinary… | Not recommended as sole replacement for PB |
| Levetiracetam monotherapy (IR), starting dose | 33 mg/kg PO q8h | Targets human therapeutic range Journal of Vete… | No minimum therapeutic concentration established in dogs Journal of Vete… |
| Levetiracetam add-on to PB 7 mg/kg/day (IR) | 72 mg/kg PO q8h (216 mg/kg/day) | Estimated to achieve ≥20 μg/mL Journal of Vete… | Dose is an estimate; individual TDM required Journal of Vete… |
| Levetiracetam extended-release + PB | 30 mg/kg PO q12h | 100% of dogs fell below 10 μg/mL at ≥1 time point Journal of Vete… | Higher doses likely needed; monitor serum levels Journal of Vete… |
| Phenobarbital monotherapy | 4 mg/kg/day PO divided q12h | 5/6 dogs were responders (≥50% seizure reduction) The Veterinary… | Target trough 15–35 μg/mL; hepatopathy risk MSD Vet Manuals |
Would you like guidance on how to monitor levetiracetam serum concentrations and adjust dosing when phenobarbital is on board?